These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 8388760

  • 1. [Treatment monitoring of patients with small cell lung cancer by determining levels of serum neuron specific enolase].
    Jassem E.
    Pneumonol Alergol Pol; 1993; 61(1-2):56-60. PubMed ID: 8388760
    [Abstract] [Full Text] [Related]

  • 2. Significance of serum neuron-specific enolase as a predictor of relapse of small cell lung cancer.
    Nitta T, Fukuoka M, Masuda N, Kusunoki Y, Matsui K, Kudoh S, Hirashima T, Yana T, Ito K, Takada M.
    Jpn J Clin Oncol; 1995 Oct; 25(5):179-83. PubMed ID: 7474404
    [Abstract] [Full Text] [Related]

  • 3. Are levels of pro-gastrin-releasing peptide or neuron-specific enolase at relapse prognostic factors after relapse in patients with small-cell lung cancer?
    Hirose T, Okuda K, Yamaoka T, Ishida K, Kusumoto S, Sugiyama T, Shirai T, Ohnshi T, Ohmori T, Adachi M.
    Lung Cancer; 2011 Feb; 71(2):224-8. PubMed ID: 20537424
    [Abstract] [Full Text] [Related]

  • 4. ProGRP and NSE in therapy monitoring in patients with small cell lung cancer.
    Wójcik E, Kulpa JK, Sas-Korczyńska B, Korzeniowski S, Jakubowicz J.
    Anticancer Res; 2008 Feb; 28(5B):3027-33. PubMed ID: 19031951
    [Abstract] [Full Text] [Related]

  • 5. Pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in therapy control of patients with small-cell lung cancer.
    Schneider J, Philipp M, Salewski L, Velcovsky HG.
    Clin Lab; 2003 Feb; 49(1-2):35-42. PubMed ID: 12593474
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of neuron-specific enolase, tissue polypeptide antigen, and carcinoembryonic antigen as markers for staging and monitoring response to therapy of lung cancer.
    Spinazzi A, Soresi E, Boffi R, Nonis A, Noseda A, Cobelli S, Scanni A.
    Cancer Detect Prev; 1994 Feb; 18(3):209-20. PubMed ID: 8076383
    [Abstract] [Full Text] [Related]

  • 7. [Evaluation of tumor markers in the management of small cell lung cancer].
    Ariyoshi Y.
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):959-65. PubMed ID: 2839115
    [Abstract] [Full Text] [Related]

  • 8. [Clinical significance of ProGRP31-98 in patients with small-cell lung cancer].
    Yang J, Li R, Li A.
    Zhonghua Zhong Liu Za Zhi; 2000 May; 22(3):216-8. PubMed ID: 11778234
    [Abstract] [Full Text] [Related]

  • 9. [Comparison of the degree of regression of small cell lung neoplasm in clinical-radiologic evaluation with levels of neuron specific enolase (NSE) in serum].
    Rowińska-Zakrzewska E, Szturmowicz M, Sakowicz A, Pawlicka L, Remiszewki P, Szopiński J, Wiatr E, Zych J.
    Pneumonol Alergol Pol; 1995 May; 63(11-12):601-8. PubMed ID: 8616474
    [Abstract] [Full Text] [Related]

  • 10. [Pre-treatment and treatment-induced neuron-specific enolase in patients with small-cell lung cancer: an open prospective study].
    Emin Erbaycu A, Gunduz A, Batum O, Zeren Ucar Z, Tuksavul F, Zeki Guclu S.
    Arch Bronconeumol; 2010 Jul; 46(7):364-9. PubMed ID: 20537457
    [Abstract] [Full Text] [Related]

  • 11. The prognostic value of both neuron-specific enolase (NSE) and Cyfra21-1 in small cell lung cancer.
    Ando S, Suzuki M, Yamamoto N, Iida T, Kimura H.
    Anticancer Res; 2004 Jul; 24(3b):1941-6. PubMed ID: 15274381
    [Abstract] [Full Text] [Related]

  • 12. Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer.
    Bonner JA, Sloan JA, Rowland KM, Klee GG, Kugler JW, Mailliard JA, Wiesenfeld M, Krook JE, Maksymiuk AW, Shaw EG, Marks RS, Perez EA.
    Clin Cancer Res; 2000 Feb; 6(2):597-601. PubMed ID: 10690544
    [Abstract] [Full Text] [Related]

  • 13. [Neuron-specific enolase (NSE) and squamous cell carcinoma antigen (SCC) as serum markers in the diagnosis of bronchial carcinoma].
    Lorenz J, Gillmann-Blum D, Jensen M, Kreienberg R.
    Pneumologie; 1990 Nov; 44(11):1259-63. PubMed ID: 2177891
    [Abstract] [Full Text] [Related]

  • 14. Serum levels of pro-gastrin-releasing peptide for follow-up of patients with small cell lung cancer.
    Okusaka T, Eguchi K, Kasai T, Kurata T, Yamamoto N, Ohe Y, Tamura T, Shinkai T, Saijo N.
    Clin Cancer Res; 1997 Jan; 3(1):123-7. PubMed ID: 9815547
    [Abstract] [Full Text] [Related]

  • 15. [Usefulness of monitoring levels of carcinoembryonic antigen, neuron-specific enolase and ferritin in serum of patients with small cell lung cancer for evaluating treatment outcome].
    Szturmowicz M, Rogińska E, Roszkowski K, Kwiek S, Filipecki S, Rowińska-Zakrzewska E.
    Pneumonol Alergol Pol; 1993 Jan; 61(9-10):489-95. PubMed ID: 8111325
    [Abstract] [Full Text] [Related]

  • 16. [Role of the cut-off value of serum neuron-specific enolase in differentiating small cell lung cancer from non-small cell lung cancer].
    Wei T, Luo RC, Zuo Q, Zhang JY, Miao JX, Lu HF.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):858-9. PubMed ID: 16793621
    [Abstract] [Full Text] [Related]

  • 17. [Serum neuron-specific enolase (NSE) in patients with small cell lung cancer--comparison with carcinoembryonic antigen (CEA)].
    Kawahara M, Furuse K, Arai R, Tsuruta M, Kodama N, Hayashi S, Kiyota M, Kubota K, Mori T, Yamamoto S.
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):146-51. PubMed ID: 3026253
    [Abstract] [Full Text] [Related]

  • 18. [The changes in serum neuron-specific enolase in patients with small cell lung cancer].
    Taitou H, Sakurai M, Tamura T, Sasaki Y, Eguchi K, Shinkai T, Ookura H, Saijo N.
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3046-9. PubMed ID: 2823722
    [Abstract] [Full Text] [Related]

  • 19. High neuron specific enolase levels in bronchoalveolar lavage fluid of patients with lung carcinoma: diagnostic value, relation to serum neuron specific enolase, and staging.
    Dowlati A, Bury T, Corhay JL, Weber T, Mendes P, Radermecker M.
    Cancer; 1996 May 15; 77(10):2039-43. PubMed ID: 8640667
    [Abstract] [Full Text] [Related]

  • 20. [Serum NSE (neuron-specific enolase) levels in small cell lung cancer, with special reference to the measurement of serial serum NSE levels].
    Kawachi S, Shimabukuro Z, Aoyama A, Yano T, Hasegawa K, Tsuboi E, Niitani H.
    Gan To Kagaku Ryoho; 1987 Aug 15; 14(8):2469-74. PubMed ID: 3039919
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.